AGP
UTHR icon

Artia Global Partners’s United Therapeutics UTHR Stock Holding History

Artia Global Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Hold
5,000
– – 0.5% 39
2026
Q1 		$2.96M Hold
5,000
– – 0.59% 32
2025
Q4 		$2.44M Hold
5,000
– – 0.35% 36
2025
Q3 		$2.1M Hold
5,000
– – 0.33% 32
2025
Q2 		$1.44M Hold
5,000
– – 0.35% 27
2025
Q1 		$1.54M Buy
+5,000
New +$1.71M 0.39% 28

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Artia Global Partners's UTHR Position: Q2 2026 in Review

Artia Global Partners held its United Therapeutics (UTHR) position steady in Q2 2026 at 5,000 shares worth $2.71M. The position accounts for 0.5% of the portfolio, ranked #39.

Artia Global Partners first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.96M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Artia Global Partners held 5,000 shares of United Therapeutics worth $2.71M as of Q2 2026.
  • Artia Global Partners left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.5% of Artia Global Partners's portfolio in Q2 2026, its #39 holding.
  • Artia Global Partners first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Artia Global Partners's United Therapeutics position peaked at $2.96M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.